biomodal team published in Nature Biotechnology!

Read about our novel technology in the Nature Biotechnology journal.

Our single-base-resolution sequencing methodology sequences complete genetics and the two most common cytosine modifications in a single workflow. This approach is accurate, requires low DNA input and has a low-barrier-to-entry as it works with existing sequencing instruments and our software deploys on existing computational set-ups. Simultaneous, phased reading of genetic and epigenetic bases provides a more complete picture of the information stored in genomes and has applications throughout biomedicine.

Keep reading

New beginnings: becoming biomodal

It all started with an epigenetic discovery Since Cambridge Epigenetix began in 2012, we’ve been innovating in the field of DNA sequencing and epigenetics. Back

CEGX Team presents at AGBT 2023

CEGX Team presents at AGBT 2023

Representatives from our R&D team presented 3 posters at the Advances in Genome Biology & Technology General Meeting in Hollywood, Florida.